Breaking News

BD to Invest $1.2B in Pre-Fillable Syringe Manufacturing Capacity

Will roll-out over the next four years and includes a new manufacturing facility in Europe.

By: Contract Pharma

Contract Pharma Staff

Global medical technology company BD (Becton, Dickinson and Company), has unveiled plans to invest approximately $1.2 billion over a 4-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS) across its six global manufacturing locations and add a new manufacturing facility in Europe.   The new manufacturing facility in Europe is expected to be operational by the end of 2023. The investment will also fund ca...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters